Physician
Patel, Harshila
Patel, Harshila was paid $1.88M by Medicaid between Jan 2018 and Nov 2024, across 54 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 44% of everything it billed.
33Billing provider infoPATEL, HARSHILA
NASHVILLE, TN 37211
NASHVILLE, TN 37211
33aNPI1497794952assigned 06/06/2006
33bProvider typePediatrics Physician
28Total paid$1.88M
24GClaims86,000
24DCodes billed54
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in Tennessee
Rank by total paid#57 of 333
Median peer was paid$139K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,625 | $174K | |
| 2019 | 11,941 | $272K | |
| 2020 | 19,043 | $366K | |
| 2021 | 15,315 | $349K | |
| 2022 | 13,211 | $309K | |
| 2023 | 9,692 | $220K | |
| 2024incomplete | 8,173 | $194K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 44% | 18,552 | 15,413 | $835K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 13% | 11,023 | 6,468 | $248K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.8% | 2,401 | 2,325 | $165K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.9% | 2,118 | 2,023 | $148K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.9% | 1,825 | 1,677 | $111K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 5.7% | 7,790 | 7,453 | $107K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.4% | 825 | 789 | $64K |
| 92552 | 2.2% | 2,331 | 2,265 | $42K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.2% | 352 | 327 | $22K |
| 90686 | <1% | 3,035 | 2,773 | $18K | |
| 99050 | <1% | 1,393 | 1,321 | $18K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,993 | 1,775 | $15K |
42 more codes
| 90697 | <1% | 388 | $15K | |
| 99173 | <1% | 3,718 | $13K | |
| 90677 | <1% | 149 | $8K | |
| 90671 | <1% | 42 | $6K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 817 | $6K |
| 90651 | <1% | 324 | $5K | |
| 90674 | <1% | 571 | $4K | |
| 36416 | <1% | 4,932 | $4K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 30 | $3K |
| 90461 | <1% | 3,169 | $3K | |
| 90670 | <1% | 1,324 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,213 | $2K |
| 90734 | <1% | 147 | $2K | |
| 90716 | <1% | 382 | $2K | |
| 0071A | <1% | 43 | $2K | |
| 81003 | <1% | 2,610 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 99 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 75 | $1K |
| 0072A | <1% | 29 | $1K | |
| 3008F | <1% | 2,399 | $1K | |
| 90707 | <1% | 406 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 593 | $958.77 |
| 99381 | <1% | 12 | $937.81 | |
| 90680 | <1% | 725 | $658.43 | |
| 90633 | <1% | 438 | $512.93 | |
| 90698 | <1% | 554 | $503.21 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 227 | $392.60 |
| 90715 | <1% | 69 | $385.48 | |
| 90744 | <1% | 276 | $183.50 | |
| A4617 | Mouth piece | <1% | 100 | $116.63 |
| 90700 | <1% | 14 | $99.99 | |
| 90696 | <1% | 74 | $40.29 | |
| 87081 | <1% | 15 | $38.90 | |
| 81001 | <1% | 33 | $37.20 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 30 | $36.82 |
| 90648 | <1% | 24 | $35.91 | |
| 99000 | <1% | 5,977 | $10.80 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 99 | $4.52 |
| A7004 | Small volume nonfiltered pneumatic nebulizer, disposable | <1% | 99 | $0.77 |
| 91307 | 0% | 76 | $0.00 | |
| 90619 | 0% | 15 | $0.00 | |
| 90687 | 0% | 45 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.